Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision?

Turning Point Brands derives over 40% of its sales from fast-growing nicotine pouches through its Fre and ALP product lines. As the FDA makes regulatory decisions on nicotine pouches and major tobacco companies enter the market, upcoming earnings will reveal whether TPB can maintain its competitive position in this expanding niche.